Efficacy of probiotic and synbiotic supplementation on metabolic syndrome in the Asian population: a systematic review and meta-analysis
Intisari Sains Medis · 26.05.2026 · 17 (2) · 471-478
DOI: 10.15562/ism.v17i2.2720 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Intisari Sains Medis, online erschienen am 26.05.2026. Verfasst von Ni Nengah Tuti Arianthi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
A group of conditions known as metabolic syndrome, which includes insulin resistance, myocardial infarction, stroke, and type II diabetes mellitus, raises the risk of atherosclerotic cardiovascular disease. The clinical symptoms of patients with metabolic syndrome are closely linked to an imbalance in gut flora, according to pertinent literature. Controlling the host's gut microbiota, which benefits the body, is a common purpose for probiotics. Probiotics' effect on metabolic syndrome has been the focus of more research in recent years; the results have been mixed. Therefore, this meta-analysis aims to determine the efficacy of probiotic and synbiotic supplementation on metabolic syndrome in Asian populations.
Methods
Preferred Reporting Items for Systematic Reviews and Meta-Analyses approach was employed in this study. PubMed, ScienceDirect, Google Scholar, the Cochrane Library, and SpringerLink were used to search the literature for research on the effectiveness of probiotic and synbiotic supplementation on metabolic syndrome in Asian populations. Bias was evaluated using ROB version 2. The analysis was performed using Review Manager 5.4.
Results
A total of 7 studies were included in this meta-analysis with a total of 439 participants. The results of the analysis showed that probiotic/synbiotic supplementation compared with control resulted in statistically significant weight loss (MD: −1.04; 95% CI: −1.95 to −0.13; p = 0.03) and reduction in fasting blood glucose levels (MD: −7.76; 95% CI: −13.53 to −1.99; p = 0.008) in an Asian population with metabolic syndrome. No significant results were found in terms of reduced BMI (MD: −0.66; 95% CI −1.37 to 0.04; p = 0.07), changes in systolic blood pressure (MD: −0.05; 95% CI −3.00 to 2.90; p = 0.97), diastolic blood pressure (MD: −2.50; 95% CI −7.90 to 2.91; p = 0.37), total cholesterol (MD: −0.17; 95% CI −0.39 to 0.05; p = 0.12), HDL (MD: 0.08; 95% CI −0.05 to 0.20; p = 0.22), LDL (MD: −0.15 with 95% CI −0.63 to 0.34; p = 0.55), triglycerides (MD: −0.77 with 95% CI −1.85 to 0.31; p = 0.16).
Conclusion
Probiotic and synbiotic supplementation can effectively improve body weight and fasting blood glucose in metabolic syndrome patients in Asian populations.
Zitieren
APA
Arianthi, N. N. T., Lestari, N. M. D. A., & Harimawan, A. I. W. (2026). Efficacy of probiotic and synbiotic supplementation on metabolic syndrome in the Asian population: a systematic review and meta-analysis. Intisari Sains Medis, 17(2), 471-478. https://doi.org/10.15562/ism.v17i2.2720
Vancouver
Arianthi NNT, Lestari NMDA, Harimawan AIW. Efficacy of probiotic and synbiotic supplementation on metabolic syndrome in the Asian population: a systematic review and meta-analysis. Intisari Sains Medis. 2026;17(2):471-478. doi:10.15562/ism.v17i2.2720
BibTeX
@article{Arianthi2026,
author = {Arianthi, Ni Nengah Tuti and Lestari, Ni Made Dwi Asti and Harimawan, Agustinus I Wayan},
title = {Efficacy of probiotic and synbiotic supplementation on metabolic syndrome in the Asian population: a systematic review and meta-analysis},
journal = {Intisari Sains Medis},
year = {2026},
volume = {17},
number = {2},
pages = {471--478},
doi = {10.15562/ism.v17i2.2720}
}
EUVIMED